TriSalus Life Sciences, Inc.

Direct answer

TriSalus Life Sciences, Inc. is publicly traded on NASDAQ under the ticker TLSI.

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which...

Can you invest in TriSalus Life Sciences, Inc.?

Yes. TriSalus Life Sciences, Inc. trades publicly on NASDAQ as TLSI.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for TriSalus Life Sciences, Inc.

Detailed equity research is provided by MarketSnap.